Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

NCT01944774 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: Nemonoxacin 500 mg
DRUG: Nemonoxacin 650 mg
DRUG: Moxifloxacin 400 mg

Sponsor

TaiGen Biotechnology Co., Ltd.

Collaborators

[object Object]
[object Object]